Angela Compton
Family · Cape Girardeau, MONPI 1619962040
Payments from drug & device makers
Across 400 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Novo Nordisk$406
- Lilly USA, LLC$384
- Amgen$374
- Astellas Pharma US Inc$241
- Abbott$210
- plus $2K from 34 others
What the payments were for
- Consulting fees$1752%
- Food & beverage$6,91698%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 184 | $3,840 |
| Novo Nordisk | 44 | $406 |
| Lilly USA, LLC | 27 | $384 |
| Amgen | 13 | $374 |
| Astellas Pharma US Inc | 15 | $241 |
| Abbott | 14 | $210 |
| AstraZeneca | 9 | $141 |
| GSK | 10 | $134 |
| Johnson & Johnson | 8 | $133 |
| Boehringer Ingelheim | 9 | $128 |
| Novartis | 7 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Merck | 4 | $61 |
| Dexcom, Inc. | 4 | $59 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Pfizer | 3 | $56 |
| Amarin Pharma, Inc. | 4 | $46 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Bayer | 2 | $40 |
| Nestle Healthcare Nutrition Inc. | 1 | $36 |
| Eisai Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Mylan Specialty L.p. | 2 | $30 |
| Exact Sciences | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $26 |
| Organon | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Corium, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Biogen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$175
How this compares
$7,091 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 20 | $21,455 |
| EliquisApixaban | 19 | $13,004 |
| XareltoRivaroxaban | 12 | $9,874 |
| MyrbetriqMirabegron | 12 | $8,063 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $950 |
| Esomeprazole Magnesium | 13 | $776 |
| Pantoprazole Sodium | 71 | $748 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $744 |
| Duloxetine Hcl | 18 | $696 |
| Gabapentin | 43 | $642 |
| Cefdinir | 37 | $589 |
| Levothyroxine Sodium | 95 | $584 |
| Doxycycline Hyclate | 53 | $520 |
| Olmesartan Medoxomil | 36 | $512 |
| Atorvastatin Calcium | 52 | $380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $384 | $21,45520 claims |
| PfizerEliquis | $56 | $13,00419 claims |
| Johnson & JohnsonXarelto | $133 | $9,87412 claims |
| Astellas Pharma US IncMyrbetriq | $241 | $8,06312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.
Other family in Cape Girardeau
- Heather MillerCape Girardeau$16K
- Michele TanzCape Girardeau$13K
- Christina CossouCape Girardeau$13K
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.